Here's Why Hold Strategy is Apt for Xylem Stock Right Now

04.06.25 16:59 Uhr

Werte in diesem Artikel
Aktien

326,60 EUR 3,10 EUR 0,96%

12,70 EUR 0,10 EUR 0,79%

111,80 EUR 1,05 EUR 0,95%

Indizes

21.761,8 PKT 214,4 PKT 0,99%

19.530,0 PKT 231,5 PKT 1,20%

6.000,4 PKT 61,1 PKT 1,03%

Xylem Inc. XYL is benefiting from solid momentum in the Measurement & Control Solutions segment, driven by robust demand for advanced technology solutions like smart metering and other applications. The Water Infrastructure segment is witnessing strength in the transport application business, supported by increased infrastructure projects in the United States. Recovery in the Applied Water segment, driven by higher demand for building solutions applications, also holds promise.Exiting first-quarter 2025, the company’s backlog totaled $5.1 billion, backed by strength across utilities, industrial and building solutions end markets. For 2025, Xylem expects to generate revenues of $8.7-$8.8 billion, indicating an increase of 1-2% on a year-over-year basis.The company intends to strengthen and expand its businesses through acquisitions. For instance, in December 2024, XYL completed the acquisition of a majority stake in Idrica. The inclusion of Idrica’s technology expanded growth opportunities for Xylem and enabled it to penetrate new markets and deliver intelligent solutions to its customers.Also, it completed the buyout of Evoqua (in May 2023), a mission-critical water treatment solutions and services provider. Evoqua’s advanced water and wastewater treatment capabilities and exposure to key industrial markets complement XYL’s portfolio of solutions across the water cycle. Acquisitions contributed $786 million to the company’s total revenues in 2024.Management remains focused on rewarding its shareholders through dividend payouts. For instance, in the first quarter 2025, Xylem paid dividends of $98 million and repurchased shares worth $12.9 million. Also, in February 2025, the company hiked its dividend rate by 11%.XYL’s Price PerformanceImage Source: Zacks Investment ResearchIn the past month, the Zacks Rank #3 (Hold) company has gained 4% compared with the industry’s 1.9% growth.Despite the positives, Xylem’s high debt levels may raise its financial obligations and drain profitability. It exited the first quarter with long-term debt of $1.97 billion. Considering its high debt level, its cash and cash equivalents of $1.06 billion do not look impressive.The company has been dealing with escalating operating costs and expenses. After witnessing a surge of 15.1% year over year in 2024, its cost of revenues increased 1.6% in the first quarter. Also, in 2024, its selling, general and administrative expenses surged 8.8% due to additional operational expenditure from the acquisition of Evoqua.Stocks to ConsiderSome better-ranked stocks from the same space are discussed below.Federal Signal Corporation FSS currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.FSS delivered a trailing four-quarter average earnings surprise of 6.4%. In the past 60 days, the Zacks Consensus Estimate for Federal Signal’s 2025 earnings has increased 1.6%.H2O America HTO currently carries a Zacks Rank of 2. HTO delivered a trailing four-quarter average earnings surprise of 23.3%. In the past 60 days, the consensus estimate for HTO’s 2025 earnings has increased 1.4%.AptarGroup, Inc. ATR presently carries a Zacks Rank of 2. ATR delivered a trailing four-quarter average earnings surprise of 7.3%. In the past 60 days, the consensus estimate for AptarGroup’s 2025 earnings has increased 5.4%.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AptarGroup, Inc. (ATR): Free Stock Analysis Report Federal Signal Corporation (FSS): Free Stock Analysis Report Xylem Inc. (XYL): Free Stock Analysis Report H2O America (HTO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Microstrategy und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Microstrategy

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Microstrategy

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Microstrategy

Wer­bung

Analysen zu Microstrategy

DatumRatingAnalyst
11.02.2019Microstrategy A BuyBWS Financial
27.10.2017Microstrategy A BuyMizuho
28.07.2017Microstrategy A HoldDeutsche Bank AG
16.11.2016Microstrategy A BuyMizuho
11.01.2016Microstrateg a BuyDeutsche Bank AG
DatumRatingAnalyst
11.02.2019Microstrategy A BuyBWS Financial
27.10.2017Microstrategy A BuyMizuho
16.11.2016Microstrategy A BuyMizuho
11.01.2016Microstrateg a BuyDeutsche Bank AG
11.12.2015Microstrateg a BuyMizuho
DatumRatingAnalyst
28.07.2017Microstrategy A HoldDeutsche Bank AG
19.10.2015Microstrateg a HoldLake Street
31.10.2012Microstrateg a neutralROTH Capital Partners, LLC
30.10.2012Microstrateg a neutralUBS AG
31.07.2012Microstrateg a neutralUBS AG
DatumRatingAnalyst
16.03.2005Update Microstrategy Inc.: SellWedbush Morgan
09.02.2005Update Microstrategy Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Microstrategy nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen